Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Serum Irisin Level Can Predict the Severity of Coronary Artery Disease in Patients with Stable Angina

  • Efe, Tolga Han (Diskapi Yildirim Beyazit Training and Research Hospital, Cardiology Clinic) ;
  • Acar, Burak (Turkiye Yuksek Ihtisas Training and Research Hospital, Cardiology Clinic) ;
  • Ertem, Ahmet Goktug (Turkiye Yuksek Ihtisas Training and Research Hospital, Cardiology Clinic) ;
  • Yayla, Kadriye Gayretli (Diskapi Yildirim Beyazit Training and Research Hospital, Cardiology Clinic) ;
  • Algul, Engin (Diskapi Yildirim Beyazit Training and Research Hospital, Cardiology Clinic) ;
  • Yayla, Cagri (Turkiye Yuksek Ihtisas Training and Research Hospital, Cardiology Clinic) ;
  • Unal, Sefa (Turkiye Yuksek Ihtisas Training and Research Hospital, Cardiology Clinic) ;
  • Bilgin, Murat (Diskapi Yildirim Beyazit Training and Research Hospital, Cardiology Clinic) ;
  • Cimen, Tolga (Diskapi Yildirim Beyazit Training and Research Hospital, Cardiology Clinic) ;
  • Kirbas, Ozgur (Turkiye Yuksek Ihtisas Training and Research Hospital, Cardiology Clinic) ;
  • Yeter, Ekrem (Diskapi Yildirim Beyazit Training and Research Hospital, Cardiology Clinic)
  • Received : 2016.02.28
  • Accepted : 2016.07.07
  • Published : 2017.01.31
⟨ Previous Next ⟩

Abstract

Background and Objectives: The recently discovered myokine irisin has a proposed role in adipose tissue metabolism. The aim of this study was to evaluate the relationship between serum irisin level and the coronary artery severity in patients with stable coronary artery disease (CAD). Subjects and Methods: Sixty-three patients who underwent coronary angiography (CA) diagnosed with stable CAD and twenty-six patients with normal coronary artery (NCA) were enrolled in the study. Stable CAD patients were divided into two groups as high synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score (${\geq}23$) and lower SYNTAX score (<23). Serum irisin level measurement was carried out using human irisin colorimetric enzyme-linked immunosorbent assay (ELISA) commercial kit (AG-45A-0046EK-KI01, Adipogen, San Diego, CA, USA) as recommended by the manufacturer's protocol. Results: The patients with stable CAD with a higher SYNTAX score (score ${\geq}23$) had significantly lower serum irisin levels ($127.91{\pm}55.38ng/mL$), as compared the patients with a low SYNTAX score (score <23) ($224.69{\pm}92.99ng/mL$) and control group ($299.54{\pm}123.20ng/mL$). Irisin levels showed significant differences between all groups (p<0.001). Conclusion: Serum irisin level is an independent predictor of coronary artery severity in patients with stable CAD.

Keywords

References

  1. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012;8:457-65. https://doi.org/10.1038/nrendo.2012.49
  2. Pedersen BK, Akerstrom TC, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. J Appl Physiol 2007;103:1093-8. https://doi.org/10.1152/japplphysiol.00080.2007
  3. Bostrom P, Wu J, Jedrychowski MP, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481:463-8. https://doi.org/10.1038/nature10777
  4. Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012;61:1725-38. https://doi.org/10.1016/j.metabol.2012.09.002
  5. Vamvini MT, Aronis KN, Panagiotou G, et al. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. Eur J Endocrinol 2013;169:829-34. https://doi.org/10.1530/EJE-13-0276
  6. Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013;98:E769-78. https://doi.org/10.1210/jc.2012-2270
  7. Crujeiras AB, Pardo M, Arturo RR, et al. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Hum Biol 2014;26:198-207. https://doi.org/10.1002/ajhb.22493
  8. Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab 2013;98:4899-907. https://doi.org/10.1210/jc.2013-2373
  9. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index. Peptides 2013;39:125-30. https://doi.org/10.1016/j.peptides.2012.11.014
  10. Liu JJ, Liu S, Wong MD, et al. Relationship between circulating irisin, renal function and body composition in type 2 diabetes. J Diabetes Complications 2014;28:208-13. https://doi.org/10.1016/j.jdiacomp.2013.09.011
  11. Choi YK, Kim MK, Bae KH, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 2013;100:96-101. https://doi.org/10.1016/j.diabres.2013.01.007
  12. Sesti G, Andreozzi F, Fiorentino TV, et al. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol 2014;51:705-13. https://doi.org/10.1007/s00592-014-0576-0
  13. Farooq V, Vergouwe Y, Raber L, et al. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. Eur Heart J 2012;33:3098-104. https://doi.org/10.1093/eurheartj/ehs295
  14. Garg S, Sarno G, Serruys PW, et al. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. JACC Cardiovasc Interv 2011;4:66-75. https://doi.org/10.1016/j.jcin.2010.09.017
  15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9. https://doi.org/10.1007/BF00280883
  16. Kuloglu T, Aydin S, Eren MN, et al. Irisin: a potentially candidate marker for myocardial infarction. Peptides 2014;55:85-91. https://doi.org/10.1016/j.peptides.2014.02.008
  17. Aydin S, Aydin S, Kuloglu T, et al. Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running. Peptides 2013;50:13-8. https://doi.org/10.1016/j.peptides.2013.09.011
  18. Liu JJ, Wong MD, Toy WC, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 2013;27:365-9. https://doi.org/10.1016/j.jdiacomp.2013.03.002
  19. Polyzos SA, Kountouras J, Anastasilakis AD, Margouta A, Mantzoros CS. Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease. Endocrine 2015;49:560-2. https://doi.org/10.1007/s12020-014-0473-x
  20. Moreno M, Moreno-Navarrete JM, Serrano M, et al. Circulating irisin levels are positively associated with metabolic risk factors in sedentary subjects. PLoS One 2015;10:e0124100. https://doi.org/10.1371/journal.pone.0124100
  21. Park SE, Park CY, Sweeney G. Biomarkers of insulin sensitivity and insulin resistance: Past, present and future. Crit Rev Clin Lab Sci 2015;52:180-90. https://doi.org/10.3109/10408363.2015.1023429
  22. Aronis KN, Moreno M, Polyzos SA, et al. Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events. Int J Obes (Lond) 2015;39:156-61. https://doi.org/10.1038/ijo.2014.101
  23. Emanuele E, Minoretti P, Pareja-Galeano H, Sanchis-Gomar F, Garatachea N, Lucia A. Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity. Am J Med 2014;127:888-90. https://doi.org/10.1016/j.amjmed.2014.04.025
  24. Lu J, Xiang G, Liu M, Mei W, Xiang L, Dong J. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Atherosclerosis 2015;243:438-48. https://doi.org/10.1016/j.atherosclerosis.2015.10.020
  25. Loffler D, Muller U, Scheuermann K, et al. Serum irisin levels are regulated by acute strenuous exercise. J Clin Endocrinol Metab 2015;100:1289-99. https://doi.org/10.1210/jc.2014-2932

Cited by

  1. Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels vol.16, pp.None, 2017, https://doi.org/10.1186/s12933-017-0627-2
  2. Association of Markers of Proinflammatory Phenotype and Beige Adipogenesis with Metabolic Syndrome in Chinese Centrally Obese Adults vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/8956509
  3. Are Heart Muscle Irisin Levels and FNDC5 Gene Expression Regulated by Endurance and Resistance Exercises? vol.6, pp.1, 2017, https://doi.org/10.29252/aassjournal.6.1.21
  4. Relationship of serum irisin levels to prevalence and progression of coronary artery calcification: A prospective, population-based study vol.267, pp.None, 2017, https://doi.org/10.1016/j.ijcard.2018.05.075
  5. Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke vol.15, pp.4, 2017, https://doi.org/10.1007/s13311-018-0651-2
  6. Decreased level of irisin, a skeletal muscle cell-derived myokine, is associated with post-stroke depression in the ischemic stroke population vol.15, pp.None, 2018, https://doi.org/10.1186/s12974-018-1177-6
  7. Irisin level in type 2 diabetic patients and its relation to glycemic control and diabetic complications vol.39, pp.4, 2017, https://doi.org/10.1007/s13410-019-00717-2
  8. Assessing cardiac irisin activities and their associations on coronary and endothelial activities to compare their recoveries from oxidative stress-induced cardiac cell injury by Chunglijagam-tang, a vol.19, pp.4, 2019, https://doi.org/10.1007/s13596-019-00364-2
  9. Lower Serum Irisin Levels Are Associated with Increased Abdominal Aortic Calcification in Peritoneal Dialysis Patients vol.7, pp.3, 2017, https://doi.org/10.1159/000512514
  10. Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/5391706
  11. Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/6644631
  12. Irisin: A New Code Uncover the Relationship of Skeletal Muscle and Cardiovascular Health During Exercise vol.12, pp.None, 2021, https://doi.org/10.3389/fphys.2021.620608
  13. Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy vol.10, pp.8, 2017, https://doi.org/10.3390/cells10082103